Marimed (MRMD) Net Income Growth (1y) (2012 - 2026)

Marimed (MRMD) Net Income Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 68.18%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -0.17%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -14.68%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -106.16%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 2,405.06%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -14.93%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 62.34%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -286.15%
10 Marimed - - 15.28 Mn 31.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 31.25%
Dec 31, 2025 43.84%
Sep 30, 2025 -197.07%
Jun 30, 2025 22.51%
Mar 31, 2025 -324.07%
Dec 31, 2024 18.49%
Sep 30, 2024 76.81%
Jun 30, 2024 -75.29%
Mar 31, 2024 -94.58%
Dec 31, 2023 -313.23%
Sep 30, 2023 -256.83%
Jun 30, 2023 -149.31%
Mar 31, 2023 -115.66%
Dec 31, 2022 174.32%
Sep 30, 2022 28.21%
Jun 30, 2022 -75.02%
Mar 31, 2022 -1.60%
Dec 31, 2021 -201.89%
Sep 30, 2021 25.19%
Jun 30, 2021 764.98%